Recruiting
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
About this study
investigate the molecular differences between primitive lung cancer and the metastatic site.
- Condition
- NSCLC, Lung Cancer (Diagnosis)
- Sponsor
- European Institute of Oncology
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: NSCLC, Lung Cancer (Diagnosis)
- patients aged ≥18 years fit enough to tolerate the surgical operation;
- the operative risk is considered low based on respiratory reserve and cardiac assessment;
- the patient has clearly expressed willingness to adhere;
- availability of pathological material for tumor DNA extraction and NGS execution.
Exclusion 3
- Women of childbearing age, pregnant or breastfeeding, or intending to become pregnant during the study.
- Any other illness, metabolic disorder, physical examination, or laboratory findings that constitute a contraindication to study participation.
- Recent or ongoing severe or clinically significant infection.
Where
1 site, 1 recruiting
Istituto Europeo di Oncologia
Milan, Italy
Contact
-
Luca Bertolaccini
+390257489244 luca.bertolaccini@ieo.it
Potential match only. Final eligibility is determined by the study team.